We are live on
!
Find out more
NTC
North Tide Capital Portfolio holdings
AUM
$469M
1-Year Est. Return
6.57%
This Fund
S&P 500
This Quarter
Est. Return
-1.68%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.31B
AUM Growth
-$117M
(-8.2%)
Cap. Flow
-$72.4M
Cap. Flow
% of AUM
-5.52%
Top 10 Holdings %
Top 10 Hldgs %
63.75%
Holding
29
New
3
Increased
6
Reduced
4
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$83.3M |
| 2 |
Viatris
VTRS
|
+$72.9M |
| 3 |
KND
Kindred Healthcare
KND
|
+$38.1M |
| 4 |
GHDX
Genomic Health, Inc.
GHDX
|
+$33.5M |
| 5 |
FRED
Fred's Inc
FRED
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$67.2M |
| 2 |
Elevance Health
ELV
|
+$64.6M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$53M |
| 4 |
SVU
SUPERVALU Inc.
SVU
|
+$50.5M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
+$49.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 81.84% |
| 2 | Consumer Discretionary | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Community Health Systems
CYH
$383M
| – | – |
-605,000
| Closed | -$22.7M |
|
|
27
Elevance Health
ELV
$82.1B
| – | – |
-600,000
| Closed | -$64.6M |
|
|
WCG
28
DELISTED
Wellcare Health Plans, Inc.
WCG
| – | – |
-900,000
| Closed | -$67.2M |
|
|
AGN
29
DELISTED
Allergan Inc
AGN
| – | – |
-200,000
| Closed | -$33.8M |
|
Similar funds
SD
DG
NBC
JWM
JPCCM
MCL
GIIO
FC
North Tide Capital's Q3 2014 Portfolio in Review
As of Q3 2014, North Tide Capital held 29 positions worth $1.31B, down 8.2% from $1.43B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
North Tide Capital withdrew a net $72.4M in Q3 2014, closing 4 positions and reducing 4 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $67.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 82% a quarter earlier, followed by Consumer Discretionary.
Against the trend, North Tide Capital opened a new position in AbbVie worth $86.6M.
- North Tide Capital's largest Q3 2014 buy was AbbVie: 1,500,000 shares worth $86.6M.
- North Tide Capital added most to Kindred Healthcare in Q3 2014, an estimated $38.1M increase.
- North Tide Capital's biggest Q3 2014 reduction was Teva Pharmaceuticals, cutting an estimated $53M.
- North Tide Capital fully exited Wellcare Health Plans, Inc. in Q3 2014, selling an estimated $67.2M.
- North Tide Capital's ten largest holdings make up 64% of its $1.31B portfolio in Q3 2014.
- North Tide Capital opened 3 new positions and closed 4 in Q3 2014.
- North Tide Capital's portfolio value fell 8.2% quarter-over-quarter to $1.31B.
Based on North Tide Capital's 13F filing for Q3 2014, filed 14 Nov 2014.